Latest Headlines

  1. Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success 10/30/2025

    Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

  2. Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio 10/29/2025

    TEMA Sinergie S.p.A., a global leader in isolation systems for the Radiopharma and Biotech Pharma industries, today announced the acquisition of a majority stake in 6Bio, a Spanish company specialized in high-performance aseptic filling technology.

  3. Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience 10/28/2025

    Avance Clinical, the award-winning Australian-led, global CRO built exclusively to service the clinical research needs of biotech companies, today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

  4. AGC Biologics Partners With Rarity PBC To Advance Life-Saving Gene Therapy For 'Bubble Baby Disease' 10/24/2025

    AGC Biologics announced an agreement with Rarity PBC to provide comprehensive development and GMP manufacturing for Rarity's gene therapy, RDP-101, for Adenosine Deaminase Severe Combined Immunodeficiency Disorder.

  5. Aseptic Filling OEM AST To Exhibit At CPHI Frankfurt 2025 10/23/2025

    From R&D and manufacturing to packaging and distribution, CPHI is where groundbreaking ideas meet the partnerships that bring them to life.

  6. Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials 10/21/2025
  7. Comecer To Exhibit Aseptic Filling Solutions At ISPE Annual Meeting 2025 10/17/2025

    Comecer will be exhibiting at the ISPE Annual Meeting & Expo 2025, on October 26 - 29 at the Charlotte Convention Center in North Carolina, USA.

  8. MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025
  9. 3P Innovation's Fill2Weight Technology Expands High-Precision Filling Capability At The CDMO, Upperton 10/16/2025
  10. Avantor® And BlueWhale Bio Partner To Accelerate CAR-T Manufacturing With Breakthrough Cell Activation And Expansion Technology 10/15/2025

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing the unmet need in CAR-T production by streamlining manufacturing, reducing variability, and shortening time-to-patient.